14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

Bio Blast Pharma Ltd. Stock Forecast

NASDAQ:ORPN BUY SELL

$5.24 (0%)

Volume: 0

Closed: May 19, 2022

Hollow Logo Score: 0.000

Bio Blast Pharma Ltd. Stock Forecast

BUY SELL NASDAQ:ORPN
$5.24 (0%)

Volume: 0

Closed: May 19, 2022

Score Hollow Logo 0.000

ORPN Stock Trend

The stock is moving within a narrow and horizontal trend and further movements within this trend can be expected.

Given the current horizontal trend, you can expect Bio Blast Pharma Ltd. stock with a 90% probability to be traded between $5.15 and $5.37 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Data

Date Bottom Mid Top
2022-05-23 $5.14 $5.25 $5.36
2022-05-24 $5.14 $5.25 $5.36
2022-05-25 $5.14 $5.25 $5.36
2022-05-26 $5.14 $5.25 $5.36
2022-05-27 $5.14 $5.25 $5.36
2022-05-31 $5.14 $5.25 $5.36
2022-06-01 $5.14 $5.25 $5.36
2022-06-02 $5.14 $5.25 $5.36
2022-06-03 $5.14 $5.25 $5.36
2022-06-06 $5.14 $5.25 $5.36
2022-06-07 $5.14 $5.25 $5.36
2022-06-08 $5.14 $5.25 $5.36
2022-06-09 $5.14 $5.25 $5.36
2022-06-10 $5.14 $5.25 $5.36
2022-06-13 $5.14 $5.25 $5.36
2022-06-14 $5.14 $5.25 $5.36
2022-06-15 $5.14 $5.25 $5.36
2022-06-16 $5.14 $5.25 $5.36
2022-06-17 $5.14 $5.25 $5.36
2022-06-21 $5.14 $5.25 $5.36
2022-06-22 $5.14 $5.25 $5.36
2022-06-23 $5.14 $5.25 $5.36
2022-06-24 $5.14 $5.25 $5.36
2022-06-27 $5.14 $5.25 $5.36
2022-06-28 $5.14 $5.25 $5.36
2022-06-29 $5.14 $5.25 $5.36
2022-06-30 $5.14 $5.25 $5.36
2022-07-01 $5.14 $5.25 $5.36
2022-07-05 $5.14 $5.25 $5.36
2022-07-06 $5.14 $5.25 $5.36

About Bio Blast Pharma Ltd.

Bio Blast Pharma Ltd., a clinical development-stage biopharmaceutical company, focuses on the identification, licensing, acquisition, development, and commercialization clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The company’s drug candidates under clinical or preclinical development includes Trehalose 90mg/mL IV solution, a mutant protein stabilizer and autophagy enhancer used for protein-based drugs ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT